Page last updated: 2024-08-23

lovastatin and Endotoxin Shock

lovastatin has been researched along with Endotoxin Shock in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Morrison, DC; Papasian, CJ; Qureshi, AA; Qureshi, N; Reis, J; Rockwell, CE; Tan, X; Vogel, SN; Yang, R	1
Goldsby, RA; Kwan, A; Margulies, DH; Natarajan, K; Osborne, BA; Quinn, M; Rajagopalan, G; Tilahun, AY; Tilahun, ME; Xie, C	1

Other Studies

2 other study(ies) available for lovastatin and Endotoxin Shock

Article	Year
A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model. Innate immunity, 2008, Volume: 14, Issue:5 Topics: Animals; Anti-Bacterial Agents; Antioxidants; Cell Death; Cell Line; Cysteine Proteinase Inhibitors; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imipenem; Lipopolysaccharides; Lovastatin; Macrophages; Mice; Nitric Oxide; Proteasome Inhibitors; Quercetin; Shock, Septic; Tumor Necrosis Factor-alpha	2008
Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB. PloS one, 2011, Volume: 6, Issue:11 Topics: Animals; Antibodies, Bacterial; Antibodies, Neutralizing; Anticholesteremic Agents; Drug Synergism; Enterotoxins; HLA-DR3 Antigen; Humans; Lovastatin; Mice; Mice, Inbred BALB C; Mice, Transgenic; Shock, Septic; Superantigens; Survival Rate	2011

Article

Year

A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model.

Innate immunity, 2008, Volume: 14, Issue:5

Topics: Animals; Anti-Bacterial Agents; Antioxidants; Cell Death; Cell Line; Cysteine Proteinase Inhibitors; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imipenem; Lipopolysaccharides; Lovastatin; Macrophages; Mice; Nitric Oxide; Proteasome Inhibitors; Quercetin; Shock, Septic; Tumor Necrosis Factor-alpha

2008

Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB.

PloS one, 2011, Volume: 6, Issue:11

Topics: Animals; Antibodies, Bacterial; Antibodies, Neutralizing; Anticholesteremic Agents; Drug Synergism; Enterotoxins; HLA-DR3 Antigen; Humans; Lovastatin; Mice; Mice, Inbred BALB C; Mice, Transgenic; Shock, Septic; Superantigens; Survival Rate

2011